Evidence map›Paper›PMID 37548815›Full record

ReviewClinical and experimental medicine2023

Circulating tumor cells in gastric cancer: developments and clinical applications.

Qian Deng, Bo Jiang, Haijiao Yan, Jun Wu, Zhenzhen Cao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qian Deng *Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.
Bo Jiang *Department of Thoracic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.
Haijiao YanDepartment of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China. haijiao8237@163.com.
Jun WuDepartment of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.
Zhenzhen CaoDepartment of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.

Funding

CSCO foundation Y-HH202101-0117the Key Program of the Changzhou Commission of Health ZD2017the Major science and technology project of Changzhou Municipal Health Commission ZD201901
6 · The paper itself

Abstract

Circulating tumor cells (CTCs), which are shed from primary tumor or metastatic sites into the bloodstream and subsequently seed into distant tissues, are considered as the precursors of metastases. Gastric cancer (GC) is a highly heterogeneous malignant tumor. With regard to the diagnosis of GC, secondary pathological biopsy is difficult, while invasive examination is harmful to patients. In recent years, CTCs have made great progress in tumor diagnosis, prognosis prediction, efficacy detection and treatment guidance, but the research on the role of CTCs in GC remains limited. The following sections review the landmark studies demonstrating the technical approaches of CTCs monitoring in the field of GC. Moreover, we highlight the clinical application of CTCs numbers and phenotypes in monitoring the therapeutic efficacy and judging patient prognosis by sequential blood analyses.

Indexed as

Neoplastic Cells, CirculatingStomach NeoplasmsBiomarkers, TumorBiopsyHumansPrognosisBiomarkers, TumorBlood analysesCirculating tumor cells (CTCs)Clinical applicationGastric cancer (GC)Technical approach

Identifiers

PMID37548815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.